Healthcare | August 03, 2021
Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
The company is confident of commencing production at both Mahad and Chiplun units soon
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever
Subscribe To Our Newsletter & Stay Updated
